91 related articles for article (PubMed ID: 7519934)
21. Antibodies to hepatitis C virus in human immunoglobulins: clinical meaning and diagnostic difficulties in children undergoing bone marrow transplant.
Mateos ML; Camarero C; Maldonado S; Lasa E; Otheo E; Muñoz A
Bone Marrow Transplant; 1994 Jul; 14(1):95-7. PubMed ID: 7524908
[TBL] [Abstract][Full Text] [Related]
22. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C.
Barrera JM; Bruguera M; Ercilla MG; Gil C; Celis R; Gil MP; del Valle Onorato M; Rodés J; Ordinas A
Hepatology; 1995 Mar; 21(3):639-44. PubMed ID: 7533121
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
24. Liver disease in patients with liver dysfunction prior to bone marrow transplantation.
Chen PM; Fan S; Hsieh RK; Liu RS; Tzeng CH; Chiou TJ; Liu JH
Bone Marrow Transplant; 1992 Jun; 9(6):415-9. PubMed ID: 1628124
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus infection and allogeneic bone marrow transplantation.
Norol F; Roche B; Girardin MF; Kuentz M; Desforges L; Cordonnier C; Duedari N; Vernant JP
Transplantation; 1994 Feb; 57(3):393-7. PubMed ID: 7509088
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation.
Locasciulli A; Bacigalupo A; Vanlint MT; Tagger A; Uderzo C; Portmann B; Shulman HM; Alberti A
Transplantation; 1991 Aug; 52(2):315-8. PubMed ID: 1714641
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to hepatocyte derived antigens and liver damage in patients after bone marrow transplantation.
Borzì RM; Meliconi R; Conte R; Bandini G; Ricci P; Miglio F; Facchini A; Gasbarrini G
Allergol Immunopathol (Madr); 1991; 19(2):63-8. PubMed ID: 1772106
[TBL] [Abstract][Full Text] [Related]
28. Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study.
Kim BK; Chung KW; Sun HS; Suh JG; Min WS; Kang CS; Sim SI; Shin WS; Kim CC
Bone Marrow Transplant; 2000 Jul; 26(2):193-7. PubMed ID: 10918430
[TBL] [Abstract][Full Text] [Related]
29. Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C.
Fan FS; Tzeng CH; Hsiao KI; Hu ST; Liu WT; Chen PM
Bone Marrow Transplant; 1991 Nov; 8(5):417-20. PubMed ID: 1662997
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up.
Strasser SI; Myerson D; Spurgeon CL; Sullivan KM; Storer B; Schoch HG; Kim S; Flowers ME; McDonald GB
Hepatology; 1999 Jun; 29(6):1893-9. PubMed ID: 10347135
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of first and second generation anti-HCV antibody tests--with special reference to their discrepancy].
Takahashi T; Iida S
Rinsho Byori; 1994 Feb; 42(2):189-94. PubMed ID: 7511185
[TBL] [Abstract][Full Text] [Related]
32. The impact of hepatitis C virus infection on renal allograft recipients.
Roth D; Zucker K; Cirocco R; DeMattos A; Burke GW; Nery J; Esquenazi V; Babischkin S; Miller J
Kidney Int; 1994 Jan; 45(1):238-44. PubMed ID: 7510350
[TBL] [Abstract][Full Text] [Related]
33. Risk of liver disease in HCV-seropositive kidney transplant recipients.
Rohr MS; Lesniewski RR; Rubin CA; Johnson RG; Heise ER; McDonald JC; Adams PL
Ann Surg; 1993 May; 217(5):512-6; discussion 516-7. PubMed ID: 8387764
[TBL] [Abstract][Full Text] [Related]
34. Impact of hepatitis C virus infection on kidney transplant outcome.
Alfurayh OI; Sobh MA; Chaudry TS; Qunibi WY; Al Meshari K; Ellis M; Ali MA; Taher S
Saudi J Kidney Dis Transpl; 1995; 6(2):183-9. PubMed ID: 18583862
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation.
Frickhofen N; Wiesneth M; Jainta C; Hertenstein B; Heymer B; Bianchi L; Dienes HP; Koerner K; Bunjes D; Arnold R
Blood; 1994 Apr; 83(7):1998-2004. PubMed ID: 7511444
[TBL] [Abstract][Full Text] [Related]
36. Role of screening for hepatitis C virus in children with malignant disease and who undergo bone marrow transplantation.
Tada K; Tajiri H; Kozaiwa K; Sawada A; Guo W; Okada S
Transfusion; 1997 Jun; 37(6):641-4. PubMed ID: 9191826
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C in patients undergoing liver transplantation.
Read AE; Donegan E; Lake J; Ferrell L; Galbraith C; Kuramoto IK; Zeldis JB; Ascher NL; Roberts J; Wright TL
Ann Intern Med; 1991 Feb; 114(4):282-4. PubMed ID: 1846278
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients.
Ljungman P; Johansson N; Aschan J; Glaumann H; Lönnqvist B; Ringdén O; Sparrelid E; Sönnerborg A; Winiarski J; Gahrton G
Blood; 1995 Aug; 86(4):1614-8. PubMed ID: 7632971
[TBL] [Abstract][Full Text] [Related]
39. [Liver changes in bone marrow transplantation].
Bruguera M; Carreras E; Cervantes F
Med Clin (Barc); 1991 Apr; 96(13):510-4. PubMed ID: 1646915
[No Abstract] [Full Text] [Related]
40. Hepatitis C virus infection in liver allograft recipients.
Caccamo L; Colledan M; Gridelli B; Rossi G; Doglia M; Gatti S; Ghidoni P; Lucianetti A; Lunghi G; Maggi U
Arch Virol Suppl; 1993; 8():291-304. PubMed ID: 7505145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
